N
Google TrendELLIOT ANDERSON (200+) — James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:elliot anderson200+sean young200+mayank yadav1000+tornado near me1000+pep guardiola500+virgil van dijk200+beşiktaş vs kocaelispor200+is zay flowers playing500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "FDA Clears First Oral Dev" (30 stories)

Top Headline Story

FDA approves Merck’s oral PCSK9 drug, a first
Lead StorySTATgeneral
Jul 16

FDA approves Merck’s oral PCSK9 drug, a first

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQeGM0WmhnOHg1aHlKUk9RdHFYYmk3dDYtZUpRbDk3d20tNHhmbzBtbFZDV1RTdXJCSUVXdmNmU0x3MUxQc0lFaTlPVUo3NXlDc0JQZ2pqdGRWSnZBMmw5Yzh0MGpZSkN4Q2N2ZnNpOC14TlV0bVNEM29VdXBINVlGNG9UdWRUNS1fVWZwamRHZU5heEliS0M1ZGtadw?oc=5" target="_blank">FDA approves Merck’s oral PCSK9 drug, a first</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+20m ago

elliot anderson

James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton

Filter stories
200+30m ago

sean young

Michael Douglas confirms Charlie Sheen put ‘c---’ sign on Sean Young during Wall Street shoot

Filter stories
1000+30m ago

mayank yadav

Gambhir: 'Bowlers' careers are at stake'

Filter stories
1000+40m ago

tornado near me

Tornado watches expire in SC; NWS tracked 2 confirmed tornadoes

Filter stories

Search Results for "FDA Clears First Oral Dev"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
CNBCgeneral

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOWFdRdDZvam5jR1o0cDVPQ1ZIa0F5Tk0wSVl6WFB5WUR0ZHh0MG9CUE5tUy11N1k5dldPVVQ1YUhUcmR2WURfcl9IallCeDEzUDg1YnZUSFlBNDhYVjlKMllBTGtoU0RqbE1jQXd5QzhBRnN0c2swRVVmSVEzSVMtdUhqZXlqcEVwSVZFTjNFVkdJb092MlRWcElVNHrSAaIBQVVfeXFMUHFxTGVRZ3VCRGl6X1dDeWFPRFVIY2xvSDd3NUNCZFVBZHZqT1prckVGeEswLUlIMDhZVFp3V1FqZndoRlprdFVCR2pZeURYbGFFZHpUVy1wN2pFazRGMFl2a1NFU19ZV2M4Q0pLLU5iczVORXRFbVJqNGdXczlvNkozZThCQlNNQXZQMTBRRVlHVmFpTEhHNi05Uk9LNzcwNW5n?oc=5" target="_blank">FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk</a>  <font color="#6f6f6f">CNBC</font>

Read Full StoryMore like this
Spero Shares Jump After FDA Clears First Oral Carbapenem Antibiotic for U.S. Market (SPRO)
Yahoo Financemarkets

Spero Shares Jump After FDA Clears First Oral Carbapenem Antibiotic for U.S. Market (SPRO)

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQSzVIUmVVLWZQTGFOaVhxNnVBMWhHSGp1OHA3aGEyTERrR1NUYWR2YlZMdW1EaURQdXkwUjlLVFhDVjl6NWxsblloMElkQlJOdTA2WWNRV1BxNW1TSXdqTjJuVVZiZWFzdW9PQU4tUE5zR0x1T1BfQXZlck5pWkZWTm1aT0tyamlsbllnVEo5N3BTbUU?oc=5" target="_blank">Spero Shares Jump After FDA Clears First Oral Carbapenem Antibiotic for U.S. Market (SPRO)</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Should you take the powerful new cholesterol pill approved by the FDA?
The Washington Postgeneral

Should you take the powerful new cholesterol pill approved by the FDA?

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNNlJQSUVnYW4za2gtOUlKbTJlY3Y4WjRpLTBJcTk5MmZ3VlNPM3Z1Y25hQzlqdkk0Z0FJUWdKSldWRnRBOXBJSlE2ejBTUUlKRTVTekI2eWlxQ1I2d0RfbGxWNFA5dmsydXBDM003QlhSWWlfWkk0WndDSUZPTkQ4cFNKa1lUZ1NiVDNSTnRCbk40dEV4MFpj?oc=5" target="_blank">Should you take the powerful new cholesterol pill approved by the FDA?</a>  <font color="#6f6f6f">The Washington Post</font>

Read Full StoryMore like this
FDA Approves Orforglipron, First Oral GLP-1 Receptor Agonist for Weight Loss With No Food or Water Restrictions
Patient Care Onlinegeneral

FDA Approves Orforglipron, First Oral GLP-1 Receptor Agonist for Weight Loss With No Food or Water Restrictions

<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQb1VLNGRCaDQ1QXhHTTF6WWdsUzUybjJzQVRrY3g4aHpMMHJ0WGNkOWJtM3VLcnNsbGR1bFB4ZlJpbW5pc2RNZEh4dlNwMVdReTM5dVVyWmZidWlkaWloNXhRbnNPS3Q1VGdaM2hkNFhsa21USFphU05KQlJqWEg1UkVCdjlibzkwYWNyVE8zeVBNZ3JmWGs1QUVCOUM3NWNkdEFsd0UwU3lqNnByUnNBdzZNdHZ0QWowNGVwMjJ6R0dkcTYxdVI4WEJSN2Zid0JiaTZkUjFQamJkTkxsTFpMU3h4Zw?oc=5" target="_blank">FDA Approves Orforglipron, First Oral GLP-1 Receptor Agonist for Weight Loss With No Food or Water Restrictions</a>  <font color="#6f6f6f">Patient Care Online</font>

Read Full StoryMore like this
FDA OKs first clinical trial testing novel oral therapy in MS patients
Multiple Sclerosis News Todaygeneral

FDA OKs first clinical trial testing novel oral therapy in MS patients

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPdWRhLVJqUi1qRmI2YWxXSVd1UWZBWjlDQ1phN2R2X2xYTWhPU3d2azZMckNyaHlTVDhxVEIzNzhERkladmVvYUZuYk9pcDhTenF3X1gxQWN5WlN3WEdDeF9aYkM5dnRfZVJaZklWdzhzQmNjZzN5S2hfOWRUamNPMVMzLUNIVkt2Mk1oSWFucFlsOWwzMHhwSkFEdGRrU1dMczFRNjd1MVJPZ0ViM0UzZlhOMUhOZVl4NzRHSEMzVTQ0Tzh6aE5VT3V2blM?oc=5" target="_blank">FDA OKs first clinical trial testing novel oral therapy in MS patients</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
FDA Approves Icotrokinra as First Targeted Oral Peptide for Moderate-to-Severe Plaque Psoriasis
Pharmacy Timesgeneral

FDA Approves Icotrokinra as First Targeted Oral Peptide for Moderate-to-Severe Plaque Psoriasis

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNM0pNSDJDTy1zWm0zNEl4N3dMQXlJU1NCMzlLZVNkNExnVG83aU9OWDFPbU5uM2JRTUk4VzZkN19aa2NTNl9TU2dxVnFGcmpFa0ZtYzd4dXpwdThVWjJhUjF6dUh3RHRqbm90SzVxeGNTdmtkNnJsSFZfVjd1YmY0ZFBOMkJmZndIU3hSeF9Sb2dtb1BJUGtDejQyWXBrUVRjR1lBYk54Z3NHX25McVdjWEhyY0JFMWVHVFU4Ty1haFRCdVhObGc2OF9R?oc=5" target="_blank">FDA Approves Icotrokinra as First Targeted Oral Peptide for Moderate-to-Severe Plaque Psoriasis</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
What an Alexander Disease Approval Means for RNA Developers
PharmTech.comgeneral

What an Alexander Disease Approval Means for RNA Developers

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQN2RwVGFJMGxGWVZkQ2RhMGYzMGRCb3I3ZnRLZldjdmhZaVM5YWNROTVsVy1IZkx1RTJMNHJaWmQySWtfWUtIdXNUMV9LR1l4RlNRNkhFeXpsTnN6ZHRiT2s5NmNDVVhHckRmbUltZlZ0amVpZGQtYkFfYy0xNk1hQWxWdGJGTGQ4VVZRSmlzelBuMUky?oc=5" target="_blank">What an Alexander Disease Approval Means for RNA Developers</a>  <font color="#6f6f6f">PharmTech.com</font>

Read Full StoryMore like this
FDA Approves Icotrokinra, First Oral IL-23 Inhibitor for Plaque Psoriasis
The American Journal of Managed Caregeneral

FDA Approves Icotrokinra, First Oral IL-23 Inhibitor for Plaque Psoriasis

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPU0Zqc1hleDlxTWM0cFMzVk1JTHE5V1B3S3pyNWRKX0g0QmF0cWppLWdBU25tQjZvVndxZDdhTkh5WnJ5aXhtc3NLQy14U0NFQ2d2THJPSnRWa1pPZGxBNUZSYndyTlhBTFFITkFDTUFPVlpja19RbzRhTXF3bWRyV2UyRWN1eXR1VnZMSWZLcXM3QzRFcUM3dklFYkZxVGc?oc=5" target="_blank">FDA Approves Icotrokinra, First Oral IL-23 Inhibitor for Plaque Psoriasis</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
Applied Clinical Trials Onlinegeneral

FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxONnp3SnR1VmJWdUpzNGJfQ2ZMUmQ0TllxYmVMN3BqcEcyXzJoSWI3T3JfM3FhM25BSmU5VVl3T3dNdW9zSVc1VzBPS1BMQjU1T2NyQko3bUxLcTBFdFJIVHVvQkVfVmtyek04M21aSE5QeWlTVHBPY0JLMjVJRlc1ZXRuT3AzTFBQRWpLMTBpN1h0R2JSZzZKdEQ2ck5taUtFbUVrbA?oc=5" target="_blank">FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results</a>  <font color="#6f6f6f">Applied Clinical Trials Online</font>

Read Full StoryMore like this
Enveda’s exercise-simulating obesity tablet clears early clinical test
BioSpacegeneral

Enveda’s exercise-simulating obesity tablet clears early clinical test

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOektOSXJnQlpZRDdlSTR5U010LUNpd3o1VkZPSGsxRkNyeFowV0F1cllwTWdMZUhya2pNVzUzeXR6U2RHbTFaZmp0cFNFQjZOX015MHNTeC0xd2VvYVUxbzEtbEs2OWYtN3QyVGJ4TVpzX1JNcFdtYlR0OXA2LXlsTG9FcTVQOUdBb2ZGSGxtQkdidWNRRFBUYlN1Z0NHRGtOVGlmZWtYRzhtdjRRUnd3UQ?oc=5" target="_blank">Enveda’s exercise-simulating obesity tablet clears early clinical test</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
With new FDA green light for developer, Parkinson’s clinical trial to launch soon
Parkinson's News Todayworld

With new FDA green light for developer, Parkinson’s clinical trial to launch soon

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxORlF0VzFIdmhRRjZNbFh2TXppeGhJVTlLb212YkJrZWU1MmNvUW5EOThNNDJ6cTYyWVVFckJERURRUkVMdVRhQ3FWZHE4TC04VjkwMFFWVmc4NllRQmNKRGdlT0Zlbm9PbWtoUmNNUG5sRHJFSlNxalI4c0JiZE9rNm83ZjRnNzE0VkgwXzdkbzMzTW1ibk8takkxMTZjZVRWTkNscHNDOV84dw?oc=5" target="_blank">With new FDA green light for developer, Parkinson’s clinical trial to launch soon</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
FDA clears first all-oral combo for first-line CLL treatment
pharmaphorumgeneral

FDA clears first all-oral combo for first-line CLL treatment

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxNU3RjcmRucURkWDRVZGc5RmJUblVsWUtYRnJHSl90OUpaQUVRS2p6eW5FX2dkd2pTVFBZb2Y3QWhkQ2tCbW5taGNfbVhhNFhIeFNPQ0Z0UnBvWVJDT3lhR3VveGE2V0dNczlHRjRmeUU0aWRETzN4SWJYMUt5bFdTRi1vdU9xTURZY2haTzFiOA?oc=5" target="_blank">FDA clears first all-oral combo for first-line CLL treatment</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
FDA clears first daily pill that could change bad cholesterol treatment
India Todaytech

FDA clears first daily pill that could change bad cholesterol treatment

<a href="https://news.google.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?oc=5" target="_blank">FDA clears first daily pill that could change bad cholesterol treatment</a>  <font color="#6f6f6f">India Today</font>

Read Full StoryMore like this
FDA approves 2 new oral gonorrhea antibiotics
CIDRAPgeneral

FDA approves 2 new oral gonorrhea antibiotics

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQRmZ5MDNCZ0piS2dvV1VyS2NveUprT2EyYzg4WXZiOUFDblg3TTRST1RaSmtFWDFvYm9vRENMcHhscmE4Z1lQOXR3LXpNdm85UFM2WkVsV2swaFZHaDRkdVlKUW9aNmpqeU1xOUhLUTR1VjZjazRua3NnZExCUTN1aVY1ZmRGZGRoUmxWdml5TnA3YmU1Mjl2emlPaGhpRUE?oc=5" target="_blank">FDA approves 2 new oral gonorrhea antibiotics</a>  <font color="#6f6f6f">CIDRAP</font>

Read Full StoryMore like this
FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
STATgeneral

FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPLWpIUjcwZXZoejQ1NVNCeHB0VGl1d3JUODNMb1kyWS16ZXBWTnI2OGtLNUNGdnpKV2l6LUItQmFSamdxSkl5TU52NkVoX0ZtQldGMHduX3pDY3JxRkZ2djl4emhtNGdNY3BLNGRoWWdCUUlxektGV2loVjE2SnRMeFBMcHI2VmVDaEJtb3hpZW1mZw?oc=5" target="_blank">FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
FDA OKs first human trial of oral MS remyelination therapy PTD802
Multiple Sclerosis News Todaygeneral

FDA OKs first human trial of oral MS remyelination therapy PTD802

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxQeTdDX0ZrUEdUYzB4ZHBnYnh3MFYwZUxQeml2OUF2VmducnRmWWpUd3BJZmF2azZnWWs4Q1hmbHZTRHIyVFVrc2xMTi1JTzB6UWVxY3I3RXJSUmZLMWRCNGJRQ2VOdGFWVUxuZll0dGNVUUVKZ0hDZ3VGVEM5dnFfOF8zQXdYNWFuVFFnRmV2Ni1NSXBMS2otLUVHM25RaEJ3ZzNhY2VyZk85eERxMXlhUlYzaUpCTEVlQXZDM25LUURTdUtqTjhrbm1SUGM?oc=5" target="_blank">FDA OKs first human trial of oral MS remyelination therapy PTD802</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
FDA's 50-Day NME Approval Changes Drug Development Rules
PharmTech.comgeneral

FDA's 50-Day NME Approval Changes Drug Development Rules

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNdzAwSmNvQjRkR2hNb0hkT0NBZE1SM3dwTEhHNlVWU05kbFMyNm1PZ0NFdDBEbXp5Y0QtSVE2cU1SNHRLaXRScm1LNW1veF9KTy0xR1RwQVdwNGF3eWRHYUVTbVZKd1pxem9PelpWajJYR2pqYWtxSGhLZzRSdkNDeGJpT0FyTGVhaWRqQjFUME0?oc=5" target="_blank">FDA's 50-Day NME Approval Changes Drug Development Rules</a>  <font color="#6f6f6f">PharmTech.com</font>

Read Full StoryMore like this
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
Patient Care Onlinegeneral

FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRFhNeXhNeGhVcEhEb0RJNTJZelVUU2phUVJhR21yVTB1MUhRYmc3cDAwVGdSVG5IZlFBU29URUhTTVYzQUJhWGJ1NU96a2NjSXlLdzZYSWxLeTFPTzdzdFZUMmdZUkZ0T0pqRnRVSXZFX0F1S0hDdS1tRDNsX0c4Rzg3cndieG5kY0RZUlpjNjZrM3pCR3BrYUV3MU1mLU1MSm5ZUjRkYXBfb2VFTlVuUktRVktwZw?oc=5" target="_blank">FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management</a>  <font color="#6f6f6f">Patient Care Online</font>

Read Full StoryMore like this
FDA Approves First Oral Peptide for Plaque Psoriasis
PharmTech.comgeneral

FDA Approves First Oral Peptide for Plaque Psoriasis

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQUV6QXdFUVZCZ1VkLTlJVDlsanpKYlBOcVp2V1VQa0J3ajhmWEZhaF83N0RGNW5qNzJTb2FKNThUb1U3SExnUm9xQXY0am1maDh6NV9VOHl5Q0F3VFkwRDJiUEY4Ulk2OExuMjNQclp1V2hhQjZQdy15RHJHWDl1NWMySjlYX0Y5aHBV?oc=5" target="_blank">FDA Approves First Oral Peptide for Plaque Psoriasis</a>  <font color="#6f6f6f">PharmTech.com</font>

Read Full StoryMore like this
FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756
Dermatology Timesgeneral

FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQeXhRVjQtOVdSX2NwT1I4dU02VTlJUDJPekxGUUdjcDV3NWgxd21MUFFITDdWN2R1N2xoMjIwS1BEaTh3VkpJd1lWR0NXTndxdUFSLXZUUjdPYzVaZ296VG1NbjdFQy1MdjhBeG5DVGpVV05YcmowUzZWWVRFeUZmUXVjY1kxRUhNRVJudU51WERDbzQtekpybDFoRHlEN3c?oc=5" target="_blank">FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
FDA approves first new gonorrhea drug in decades
STATgeneral

FDA approves first new gonorrhea drug in decades

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOWUQ4bkZmZ1d2YjNmS3QzeVhDdjgzd1R1Zm1WSThXZktpZ3Rmb182RzN5aXhQMnRhWG9BVGVJS0pqN3RZaV9RMElRTGZVNlhRSmd3cWtRSl95ZWx3SFlfNVFVSnVra09Va3Y5c2F5RzN4S25TS29BLTZ0bXh1SjlsREFhUzlzMjFOVENfQkpWM2xrY213WUE?oc=5" target="_blank">FDA approves first new gonorrhea drug in decades</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease
BioSpacegeneral

Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease

<a href="https://news.google.com/rss/articles/CBMiwgJBVV95cUxOZ1RSTlpMZm1zeUx4QlQ0Y0dOUHI5NU9xSFRQVVdJcVRhQW5rTXlwVTMyaElnOTZKb19tTjFGVG1Ednd6bGpOd19zUHE0QTZ0UW5UNHZSdUl0Vkp3QllCNFVCY0oxOUF6TWZGSXZhcXBKXzRIMUhKN3NNem90N2xvek5kWUtDWVZtX0NJMnFhUE1YQ2FIWlFrRGtFb3pJcGdNN1BWSmp3WUJfVjhHVHlKLWNYTFY3dDRMSk1LOU1aWkNGUk12TFZ1ZzhuWmVpd3VvaWlGbHdDUExlSExJX1hyOUJwZm5jRkxaNEJVNWlSLTkwV1RjR3U2WWx6aUVqZExqNkZGMy1ISXRlOVpySW1uZ0lvbzhxaURFb05UYjEydUxSeUljM3pOUlh6aWxqNDFhaWpuZFB1LXFwNVlXeHZ5Tmt3?oc=5" target="_blank">Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
MedPage Todaygeneral

FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE0tQUp0N1VIeF9ObFpfZEcwTFViZURDQnFHT01aWXJMVHdTUDdmdkZQbmx4d1NLU1JaVEdDb2NjQ1p2UlFQZjZpM05oaDlhOEVIR3B5NzlqOGEyM1JvMkMzVUM0N2o4TVp1Mm9nQWk1UzBWUQ?oc=5" target="_blank">FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
FDA approves first oral treatments for gonorrhea in decades
The National Deskgeneral

FDA approves first oral treatments for gonorrhea in decades

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxQbWxVWkVEdzQ3WWtrZkNkc2ZidXFnVGhzM1VlSXV4WnI5dWU5Qzl6U2ZCYUl4RXQ5R0o1YW5iRFN2eXpUdTJ4bGg2Rk0ydVFpQVRJOFRaS3ZNSklqUWE4azZJbW1CRHYyc0hHWmhnUmlpWkxwVm9aUWw0U3lDTlhtQml5YzVaMGlFeDhFNUE3aGxsMVdpdUkzajZWS2MxWkYwVlU4a2h3NW1lcVYtZlJlU3BBdXVnWTZRQkJEMFV6RFNTbUdiaU1ZdFdmN2lZdThTdHpQOEduUnc5Mkx5RGIyOUdoWWY2am5sU1NBdjJ3cHloNGNsWDVXZlFEUmk4cDBjYUhueWF5QUx4ZG1VdGhHdmdaMXhMUzM2M3ZraHZNZFp0NWFjcnIzaFBEREpfcDI3YTRz?oc=5" target="_blank">FDA approves first oral treatments for gonorrhea in decades</a>  <font color="#6f6f6f">The National Desk</font>

Read Full StoryMore like this
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
The American Journal of Managed Caregeneral

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPdDVsRncyNDJIWU42X1AzblQyZVh3bEJzeUlfUUU1VXFiM0Nabk1ZUXBCS1hkS0Z5V3paRm1xUHdVeTc4UzlmTkZGTEFubmw5SVozTHpHT3E0eWdYQlFVcWJ1d1lGZnF2dGxPV3ZtMHE4WC14NU41a2lrS2lEdG1pdFlhdHVTanJzeVlBajl2T1JRbWhBdnc?oc=5" target="_blank">FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Read Full StoryMore like this
FDA Approves Enlicitide, an Oral PCSK9 Inhibitor, for LDL-Lowering
TCTMD.comgeneral

FDA Approves Enlicitide, an Oral PCSK9 Inhibitor, for LDL-Lowering

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQd1VQZEQ4WkdGdUcyaXV5dXBHZk5WdnVXbWM0STltWVpkNTVkdm9YMVZIWVRqdFNTQms3am5NMENZUVFOaWZTX3hiSG5DM2JsRGxlWlBMckJZX3VaeUVYeWIzSTJPOGpCZHhDOHdPcGZib2Utdk82MTVkSGVkQzB2LWx0bW84NVpHSnozNw?oc=5" target="_blank">FDA Approves Enlicitide, an Oral PCSK9 Inhibitor, for LDL-Lowering</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
GlobeNewswiregeneral

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxNZzNlUGg2dkNZSnlabkFHanBVWDk5Z2pEX2pCUXk1OHpuXzc4UlFsaEhQRXJDczNNZVg2YWY4bld4eldpUU9McWFGRUlMWGhyRmhaLVI5T2tNa1ZtVkZBZTVScUhjdXVVekxQNkp1bGRudXRmc3FnSEsxd3lMeG9wZU14VGZ4QzFKMVZlVHFTQkJ0T0pOQ0NzYUVIUmY2dWZZZnFtOGRfYThtZjNMOC1Wby01RU9XbjFmMzFxRHdtd2lvbmF0NzdPWmc0TmpvbUhCbWJwbVBzMUZ5ZFZJTlpPS0tfZFpyZkVtRWtFZlVJR05kcWxDV0tzMWdGWEg?oc=5" target="_blank">FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
FDA Clears First Oral Appliances to Treat Severe OSA
Sleep Reviewgeneral

FDA Clears First Oral Appliances to Treat Severe OSA

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQby1lN19iN0VJVkFFeEg3aW0taXRQVzlCQXVuRWFhZkg5cHBTZG9rSUFqS0RCdnRyTXhSOElCWUdiYkw4ajl5YW4wZFBRUW9vaVFHZ0pNNzgwMXdwTXJQVW5Xb0dxM29wQUFwOWxUbzhuUmJ2aF84VTR2T01iemtmOFRMLVN1dVF0d2xSdHQwTG5HVUF2MnRLUzk5ZjlkdDVBOUZiYUwtUFBmYk90bEpfR2JPY1g?oc=5" target="_blank">FDA Clears First Oral Appliances to Treat Severe OSA</a>  <font color="#6f6f6f">Sleep Review</font>

Read Full StoryMore like this
Tavapadon, now Juvmo, wins FDA approval for treating Parkinson's
Parkinson's News Todaygeneral

Tavapadon, now Juvmo, wins FDA approval for treating Parkinson's

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOMDNMVUF1SndscjlxZXBNd1dqQm5wNFllRHRSbnJOTUZhTkczdzh4d0Ria2FMX1pSNmwwSjhucV8temVNYjFsSGVSdFU2YzJIWURDY3ZVR1NvNnRaMHNMeXFOUW5hbU5SNU5aSG8yY3M2bXQ1UDRPdWJrU0ZBZDl4anhuM2RoMVFTUTdiMTE1Y3RzQ0RyZk1YQVlXU29vNDJtMnJB?oc=5" target="_blank">Tavapadon, now Juvmo, wins FDA approval for treating Parkinson's</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
"FDA Clears First Oral Dev" — Live Google News Trends & Headlines